表紙:鎮痛剤市場:世界の業界動向、シェア、規模、成長、機会、予測(2022年~2027年)
市場調査レポート
商品コード
1058382

鎮痛剤市場:世界の業界動向、シェア、規模、成長、機会、予測(2022年~2027年)

Analgesics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

出版日: | 発行: IMARC Services Private Limited | ページ情報: 英文 110 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=136.22円
鎮痛剤市場:世界の業界動向、シェア、規模、成長、機会、予測(2022年~2027年)
出版日: 2022年02月12日
発行: IMARC Services Private Limited
ページ情報: 英文 110 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の鎮痛剤の市場規模は、2021年に490億2,000万米ドルに達しました。今後、2022年~2027年にかけて4.5%のCAGRで拡大し、2027年には645億9,000万米ドルに達すると予測されています。

鎮痛剤の需要を促進する主な要因は、高齢者人口の増加です。2050年には、世界の総人口の約21%を占めると予想されています。高齢者は慢性疾患や生活習慣病にかかりやすいため、鎮痛剤の売上に大きく貢献すると考えられます。

当レポートでは、世界の鎮痛剤市場について調査し、市場の概要とともに、薬剤クラス別、投与経路別、疼痛タイプ別、用途別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 序文

第2章 範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界の鎮痛剤市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 薬剤クラス別市場の内訳
  • 投与経路別市場の内訳
  • 疼痛タイプの市場の内訳
  • 用途別市場の内訳
  • 地域別市場の内訳

第6章 市場の内訳、タイプ別

  • 処方薬
  • 市販薬

第7章 市場の内訳、薬剤クラス別

  • オピオイド
  • NSAID
  • その他

第8章 市場の内訳、投与経路別

  • 経口
  • 非経口
  • 局所
  • 経皮
  • 直腸

第9章 市場の内訳、疼痛タイプ別

  • 筋骨格
  • 外科・外傷
  • 神経障害性
  • 片頭痛
  • 産科
  • 線維筋痛症
  • 火傷による疼痛
  • 歯科/顔面
  • 小児科
  • その他

第10章 市場の内訳、用途別

  • 内服薬
  • 外用薬

第11章 市場の内訳、地域別

  • 北米
  • 欧州
  • アジア太平洋
  • 中東・アフリカ
  • ラテンアメリカ

第12章 世界の鎮痛剤業界:SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第13章 世界の鎮痛剤業界:バリューチェーン分析

  • 概要
  • 研究開発
  • 原材料調達
  • 製造
  • マーケティング
  • 流通
  • 最終用途

第14章 世界の鎮痛剤業界:ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 売り手の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第15章 世界の鎮痛剤業界:価格分析

  • 価格指標
  • 価格構造
  • マージン分析

第16章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Bayer AG
    • Novartis International AG
    • GlaxoSmithKline PLC
    • Pfizer Inc.
    • Johnson & Johnson Pvt. Ltd.
    • Reckitt Benckiser(RB)Group PLC
    • Endo Pharmaceuticals PLC
    • Bristol-Myers Squibb Company
    • Eli Lilly and Company
    • Sanofi SA
図表

List of Figures

  • Figure 1: Global: Analgesics Market: Major Drivers and Challenges
  • Figure 2: Global: Analgesics Market: Sales Value (in Billion US$), 2016-2021
  • Figure 3: Global: Analgesics Market: Breakup by Type (in %), 2021
  • Figure 4: Global: Analgesics Market: Breakup by Drug Class (in %), 2021
  • Figure 5: Global: Analgesics Market: Breakup by Route of Administration (in %), 2021
  • Figure 6: Global: Analgesics Market: Breakup by Pain Type (in %), 2021
  • Figure 7: Global: Analgesics Market: Breakup by Application (in %), 2021
  • Figure 8: Global: Analgesics Market: Breakup by Region (in %), 2021
  • Figure 9: Global: Analgesics Market Forecast: Sales Value (in Billion US$), 2022-2027
  • Figure 10: Global: Analgesics Industry: SWOT Analysis
  • Figure 11: Global: Analgesics Industry: Value Chain Analysis
  • Figure 12: Global: Analgesics Industry: Porter's Five Forces Analysis
  • Figure 13: Global: Analgesics (Prescription) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 14: Global: Analgesics (Prescription) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 15: Global: Analgesics (Over the counter-OTC) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 16: Global: Analgesics (Over the counter-OTC) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 17: Global: Analgesics (Opioids) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 18: Global: Analgesics (Opioids) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 19: Global: Analgesics (NSAID) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 20: Global: Analgesics (NSAID) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 21: Global: Analgesics (Others) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 22: Global: Analgesics (Others) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 23: Global: Analgesics (Oral) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 24: Global: Analgesics (Oral) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 25: Global: Analgesics (Parenteral) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 26: Global: Analgesics (Parenteral) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 27: Global: Analgesics (Topical) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 28: Global: Analgesics (Topical) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 29: Global: Analgesics (Transdermal) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 30: Global: Analgesics (Transdermal) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 31: Global: Analgesics (Rectal) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 32: Global: Analgesics (Rectal) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 33: Global: Analgesics (Musculoskeletal) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 34: Global: Analgesics (Musculoskeletal) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 35: Global: Analgesics (Surgical and Trauma) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 36: Global: Analgesics (Surgical and Trauma) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 37: Global: Analgesics (Cancer) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 38: Global: Analgesics (Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 39: Global: Analgesics (Neuropathic) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 40: Global: Analgesics (Neuropathic) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 41: Global: Analgesics (Migraine) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 42: Global: Analgesics (Migraine) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 43: Global: Analgesics (Obstetrical) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 44: Global: Analgesics (Obstetrical) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 45: Global: Analgesics (Fibromyalgia) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 46: Global: Analgesics (Fibromyalgia) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 47: Global: Analgesics (Pain due to Burns) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 48: Global: Analgesics (Pain due to Burns) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 49: Global: Analgesics (Dental/Facial) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 50: Global: Analgesics (Dental/Facial) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 51: Global: Analgesics (Pediatric) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 52: Global: Analgesics (Pediatric) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 53: Global: Analgesics (Other Pain Types) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 54: Global: Analgesics (Other Pain Types) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 55: Global: Analgesics (Internal) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 56: Global: Analgesics (Internal) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 57: Global: Analgesics (External) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 58: Global: Analgesics (External) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 59: North America: Analgesics Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 60: North America: Analgesics Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 61: Europe: Analgesics Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 62: Europe: Analgesics Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 63: Asia Pacific: Analgesics Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 64: Asia Pacific: Analgesics Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 65: Middle East and Africa: Analgesics Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 66: Middle East and Africa: Analgesics Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 67: Latin America: Analgesics Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 68: Latin America: Analgesics Market Forecast: Sales Value (in Million US$), 2022-2027

List of Tables

  • Table 1: Global: Analgesics Market: Key Industry Highlights, 2021 and 2027
  • Table 2: Global: Analgesics Market Forecast: Breakup by Type (in Million US$), 2022-2027
  • Table 3: Global: Analgesics Market Forecast: Breakup by Drug Class (in Million US$), 2022-2027
  • Table 4: Global: Analgesics Market Forecast: Breakup by Route of Administration (in Million US$), 2022-2027
  • Table 5: Global: Analgesics Market Forecast: Breakup by Pain Type (in Million US$), 2022-2027
  • Table 6: Global: Analgesics Market Forecast: Breakup by Application (in Million US$), 2022-2027
  • Table 7: Global: Analgesics Market Forecast: Breakup by Region (in Million US$), 2022-2027
  • Table 8: Global: Analgesics Market Structure
  • Table 9: Global: Analgesics Market: Key Players
目次
Product Code: SR0222A233_Report

The global analgesics market reached a value of US$ 49.02 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 64.59 Billion by 2027, exhibiting a CAGR of 4.5% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Analgesics, also known as painkillers or pain relievers, are drugs that help in relieving pain without affecting consciousness, altering sensory perception, or blocking nerve impulse conduction. These drugs include paracetamol (known as acetaminophen or simply APAP in North America), nonsteroidal anti-inflammatory drugs (NSAIDs) such as the salicylates, and opioid drugs such as morphine and oxycodone. Analgesics are used for treating pain resulting from physiological injuries, surgeries, phantom aches, inflammation, neuropathic conditions and cancer treatments. Nowadays, rising internet penetration has enabled various e-commerce platforms to collaborate with pharmaceutical manufacturers to deliver drugs like analgesics at the doorstep of consumers.

The primary factor catalyzing the demand for analgesics is the increasing geriatric population. In 2017, between 950-1000 million people were over the age of 60. However, by 2050, these numbers are expected to reach 2100 million, accounting for around 21% of the total global population. As older adults are more vulnerable to chronic and lifestyles diseases, it will significantly contribute to the sales of analgesics. Apart from this, many leading pharmaceutical companies are continually focusing on clinical advancements in both the delivery and design of analgesic drugs. They are also developing safer opioids with improved side effect profiles and effective pain relief. Moreover, the presence of a strong drug pipeline with efficacious drugs waiting for approvals by the United States Food and Drug Administration (USFDA) is further expected to enhance the use of analgesics across the globe.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global analgesics market, along with forecasts at the global and regional level from 2022-2027. Our report has categorized the market based on type, drug class, route of administration, pain type and application.

Breakup by Type:

  • Prescription
  • Over the counter (OTC)
  • Prescription analgesics currently represent the most popular drug type across the globe.

Breakup by Drug Class:

  • Opioids
  • NSAID
  • Others
  • Based on the drug class, opioids dominate the market as they are widely used in cancer pain management and end-stage diseases in which palliative care is required.

Breakup by Route of Administration:

  • Oral
  • Parenteral
  • Topical
  • Transdermal
  • Rectal
  • Amongst these, oral is the most common route of administration (ROA) since it is considered to be one of the safest ROA and requires minimal to no medical assistance.

Breakup by Pain Type:

  • Musculoskeletal
  • Surgical and Trauma
  • Cancer
  • Neuropathic
  • Migraine
  • Obstetrical
  • Fibromyalgia
  • Pain due to Burns
  • Dental/Facial
  • Pediatric
  • Others
  • At present, musculoskeletal pain accounts for the majority of the global market share. It is most often caused by an injury to the bones, joints, muscles, tendons, ligaments, or nerves.

Breakup by Application:

  • Internal
  • External
  • Presently, internal analgesics exhibit a clear dominance in the market. They are intended for internal use and are either taken by mouth in the form of pills and liquids or inserted into the rectum in suppository form.

Regional Insights:

  • Asia Pacific
  • North America
  • Europe
  • Middle East and Africa
  • Latin America
  • On the geographical front, North America enjoys the leading position in the market. This can be attributed to the rising penetration of generics, coupled with the growing healthcare expenditure in the region.

Competitive Landscape:

The market has also been examined with the presence of numerous small and large manufacturers who compete in terms of prices and quality. Some of the leading players are:

  • Bayer AG
  • Novartis International AG
  • GlaxoSmithKline PLC
  • Pfizer Inc.
  • Johnson & Johnson Pvt. Ltd.
  • Reckitt Benckiser (RB) Group PLC
  • Endo Pharmaceuticals PLC
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company

Sanofi SA Key Questions Answered in This Report:

  • How has the global analgesics market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global analgesics market?
  • What is the breakup of the market on the basis of type?
  • What is the breakup of the market on the basis of drug class?
  • What is the breakup of the market on the basis of route of administration?
  • What is the breakup of the market on the basis of pain type?
  • What is the breakup of the market on the basis of application?
  • What are the various stages in the value chain of the global analgesics market?
  • What are the key driving factors and challenges in the global analgesics market?
  • What is the structure of the global analgesics market and who are the key players?
  • What is the degree of competition in the global analgesics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Analgesics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Type
  • 5.5 Market Breakup by Drug Class
  • 5.6 Market Breakup by Route of Administration
  • 5.7 Market Breakup by Pain Type
  • 5.8 Market Breakup by Application
  • 5.9 Market Breakup by Region
  • 5.10 Market Forecast

6 Market Breakup by Type

  • 6.1 Prescription
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Over the counter (OTC)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Drug Class

  • 7.1 Opioids
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 NSAID
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Oral
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Parenteral
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Topical
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Transdermal
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Rectal
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Pain Type

  • 9.1 Musculoskeletal
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Surgical and Trauma
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Cancer
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Neuropathic
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Migraine
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast
  • 9.6 Obstetrical
    • 9.6.1 Market Trends
    • 9.6.2 Market Forecast
  • 9.7 Fibromyalgia
    • 9.7.1 Market Trends
    • 9.7.2 Market Forecast
  • 9.8 Pain due to Burns
    • 9.8.1 Market Trends
    • 9.8.2 Market Forecast
  • 9.9 Dental/Facial
    • 9.9.1 Market Trends
    • 9.9.2 Market Forecast
  • 9.10 Pediatric
    • 9.10.1 Market Trends
    • 9.10.2 Market Forecast
  • 9.11 Others
    • 9.11.1 Market Trends
    • 9.11.2 Market Forecast

10 Market Breakup by Application

  • 10.1 Internal
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 External
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 Market Trends
    • 11.1.2 Market Forecast
  • 11.2 Europe
    • 11.2.1 Market Trends
    • 11.2.2 Market Forecast
  • 11.3 Asia Pacific
    • 11.3.1 Market Trends
    • 11.3.2 Market Forecast
  • 11.4 Middle East and Africa
    • 11.4.1 Market Trends
    • 11.4.2 Market Forecast
  • 11.5 Latin America
    • 11.5.1 Market Trends
    • 11.5.2 Market Forecast

12 Global Analgesics Industry: SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Global Analgesics Industry: Value Chain Analysis

  • 13.1 Overview
  • 13.2 Research and Development
  • 13.3 Raw Material Procurement
  • 13.4 Manufacturing
  • 13.5 Marketing
  • 13.6 Distribution
  • 13.7 End-Use

14 Global Analgesics Industry: Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Global Analgesics Industry: Price Analysis

  • 15.1 Price Indicators
  • 15.2 Price Structure
  • 15.3 Margin Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Bayer AG
    • 16.3.2 Novartis International AG
    • 16.3.3 GlaxoSmithKline PLC
    • 16.3.4 Pfizer Inc.
    • 16.3.5 Johnson & Johnson Pvt. Ltd.
    • 16.3.6 Reckitt Benckiser (RB) Group PLC
    • 16.3.7 Endo Pharmaceuticals PLC
    • 16.3.8 Bristol-Myers Squibb Company
    • 16.3.9 Eli Lilly and Company
    • 16.3.10 Sanofi SA